Health News

US and European Regulators Accept for Review OMS302 Marketing Applications

Author: Australian Business

SEATTLE, Oct. 2, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) announced today that the New Drug Application (NDA) for its ophthalmology product, OMS302, has been confirmed for filing by the U.S. Food and Drug Administration (FDA), which means that the application, submitted......

More...

More Articles...

El NHS de Inglaterra designa a SIRT (radioterapia interna selectiva) como el primer tratamiento disponible a través de la nueva iniciativa "Commissioning through Evaluation"
Expatriates Could be Paying Too Much For International Private Medical Insurance
NHS England torna a SIRT (Radioterapia Seletiva Interna) o primeiro tratamento disponível através da nova iniciativa de comissionamento por avaliação
KLOX Technologies annonce l'approbation au Canada de son traitement novateur contre l'acné simple
Nutranomics Receives Purchase Order from GNC Franchise Owners in the Philippines
VG Life Sciences, Inc. Closes on $2,235,000 from Private Fund
Americans View Walking as Good for Health But Many Aren't Walking Enough to Realize Health Benefits: Survey
Improving The Self-Esteem Of The World
Cymetrix Names New Senior Vice President, Compliance
Hammond Pond Dental, of Chestnut Hill, MA, Offers Support for Troops with Halloween Candy BuyBack Program

Page 1265 of 1908